ISATUXIMAB-IRFC | B761113 | SANOFI AVENTIS US
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Mar. 2, 2032 | Active | Computed |
| 7-Year Orphan | Sep. 20, 1931 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12391728(manufacturing) · relevance 65/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Top 50 of 75 AI-discovered patents by relevance.
No patent or exclusivity listings for this strength.